Int J Med Sci 2018; 15(6):603-609. doi:10.7150/ijms.24492 This issue Cite

Research Paper

Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases

Young-Sun Lee1, Hee-Sook Jun1,2,3✉

1. Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, 406-840, Republic of Korea
2. College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, Incheon, 406-840, Republic of Korea
3. Gachon Medical Research Institute, Gil Hospital, Incheon, 405-760, Republic of Korea

Citation:
Lee YS, Jun HS. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases. Int J Med Sci 2018; 15(6):603-609. doi:10.7150/ijms.24492. https://www.medsci.org/v15p0603.htm
Other styles

File import instruction

Abstract

Diabetes mellitus is a chronic disease in which the pancreas no longer produces enough insulin. Pancreatic alpha cell mass increases in response to insufficient insulin secretion. However, the reason for this increase is not clear. It is possible that the increased alpha-cells may stimulate compensatory insulin release in response to the insufficient insulin such as insulin resistance. In this study, we investigated whether glucagon and glucagon-like peptide-1 (GLP-1), hormones produced by alpha cells, contribute to insulin secretion in INS-1 cells, a beta cell line. We confirmed that alpha cell area in the pancreatic islets and glucagon secretion were increased in HFD-induced obese mice. Co-treatment with glucagon and exendin-4 (Ex-4), a GLP-1 receptor agonist, additively increased glucose-stimulated insulin secretion in INS-1 cells. In parallel, cAMP production was also additively increased by co-treatment with these hormones. The increase of insulin secretion by Ex-4 in the presence of high glucose was inhibited by 2'5'-dideoxyadenosine, a transmembrane adenylyl cyclase inhibitor, but not by KH-7, a soluble adenylyl cyclase inhibitor. The increase of insulin secretion by glucagon in INS-1 cells was inhibited by both 2'5'-dideoxyadenosine and KH-7. We suggest that glucagon and GLP-1 produced from alpha cells additively increase cAMP and insulin secretion in the presence of high glucose via distinct adenylyl cyclases in INS-1 cells, and this may contribute to the compensatory increase of insulin secretion by an increase of pancreatic alpha cell mass under conditions of insulin resistance.

Keywords: Glucagon-like peptide-1, glucagon, insulin secretion, beta cell, alpha cell


Citation styles

APA
Lee, Y.S., Jun, H.S. (2018). Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases. International Journal of Medical Sciences, 15(6), 603-609. https://doi.org/10.7150/ijms.24492.

ACS
Lee, Y.S.; Jun, H.S. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases. Int. J. Med. Sci. 2018, 15 (6), 603-609. DOI: 10.7150/ijms.24492.

NLM
Lee YS, Jun HS. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases. Int J Med Sci 2018; 15(6):603-609. doi:10.7150/ijms.24492. https://www.medsci.org/v15p0603.htm

CSE
Lee YS, Jun HS. 2018. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases. Int J Med Sci. 15(6):603-609.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image